| Income Statement |
| Total Revenue | 39.84M |
|
| Revenues (USD) | 39.84M |
| Cost of Revenue | 23.62M |
| Gross Profit | 16.22M |
| Operating Expenses | 22.68M |
| Research and Development Expense | 5.58M |
| Selling, General and Administrative Expense | 17.10M |
| Operating Income | -6.46M |
| Interest Expense | 89.00K |
| Income Tax Expense | -162.00K |
| Net Income | -5.64M |
| Net Income Common Stock | -5.64M |
| Net Income Common Stock (USD) | -5.64M |
| Consolidated Income | -5.64M |
| Earnings per Basic Share | -0.03 |
| Earnings per Basic Share (USD) | -0.03 |
| Earnings per Diluted Share | -0.03 |
| Earning Before Interest & Taxes (EBIT) | -5.71M |
| Earning Before Interest & Taxes (USD) | -5.71M |
| Weighted Average Shares | 192.41M |
| Weighted Average Shares Diluted | 192.41M |
| Balance Sheet |
| Cash and Equivalents | 92.66M |
| Cash and Equivalents (USD) | 92.66M |
| Trade and Non-Trade Receivables | 38.10M |
| Current Assets | 162.40M |
| Property, Plant & Equipment Net | 4.69M |
| Total Assets | 293.70M |
| Current Liabilities | 42.68M |
| Total Liabilities | 68.56M |
| Accumulated Retained Earnings (Deficit) | -426.78M |
| Accumulated Other Comprehensive Income | 283.00K |
| Shareholders Equity | 225.14M |
| Shareholders Equity (USD) | 225.14M |
| Assets Non-Current | 131.30M |
| Deferred Revenue | 39.67M |
| Goodwill and Intangible Assets | 109.90M |
| Inventory | 21.33M |
| Liabilities Non-Current | 25.88M |
| Trade and Non-Trade Payables | 8.46M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 2.40M |
| Net Cash Flow from Financing | -3.51M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.16M |
| Capital Expenditure | -1.86M |
| Issuance (Purchase) of Equity Shares | -3.34M |
| Net Cash Flow from Investing | -1.86M |
| Net Cash Flow from Operations | -1.69M |
| Effect of Exchange Rate Changes on Cash | 901.00K |
| Share Based Compensation | 3.23M |